ONS Gathers Healthcare Experts, Government Agencies for Policy Summit
Nurse practitioners (NPs) are key to improving the quality of care for their patients with cancer through advocacy—both in institutions across the country and in legislative offices on Capitol Hill. With the intent to remove barriers so NPs can help move the needle for healthcare policy, ONS’s Center for Advocacy and Health Policy held the summit, “Policy Barriers and Opportunities to NPs in Oncology,” on April 10, 2018, in Washington, DC.
Key Funding Increases for Cancer Research, Nursing, Public Health; Patients, Providers, or Politicians: Whose Choices Matter Most?; FDA Targets Flavored Tobacco Products
Racing against the clock to ensure the government stayed funded through September 2018, President Trump signed the Consolidation Appropriations Act, a $1.3 trillion spending bill that includes funding for a number of key nursing and public health initiatives. The bill, which had made its way through the House of Representatives and the Senate last week, also contains new clarifying language for the Dickey Amendment, ending a 22-year ban on government-funded gun violence research. ONS joined the Nursing Community Coalition—led in part by the efforts of the American Nurses Association—to support evidence-based inquiry into gun violence and its potential impacts on public health.
NCI Updates Cancer Trends Progress Report
The National Cancer Institute (NCI) has proactively shared new information and trends with the general public. Through its Cancer Trends Progress Report, NCI provides descriptions of research and data to help review past experiences and assist the agency in planning for future research funding.
Cancer Moonshot Offers Funding Opportunities
Since its initial announcement, the National Cancer Moonshot Initiative—dubbed the Biden Cancer Initiative—has captivated the scientific, patient advocacy, and provider communities with possibilities for advancements in cancer treatments and cures. The cancer moonshot continues to maintain bipartisan support, as all involved are committed to making a decade’s worth of progress in just half the time.
NCI Advancements Are Pushing Research Forward for Patients
Former U.S. Senator Arlen Specter (R-PA) put partisanship aside to support federal funding for biomedical research. And, while battling cancer himself, he spoke about the National Institutes of Health (NIH) and its crucial role in finding treatments and cures. “Health is our nation’s number one asset. Without your health, you can’t do anything. I believe medical research should be pursued with all possible haste to cure the diseases and maladies affecting Americans. I have said many times that the NIH is the crown jewel of the federal government—perhaps the only jewel of the federal government.”
New Director Sworn in at NCI
For the past two years, an acting director has served at the head of the National Cancer Institute (NCI). However, President Trump recently selected Norman E. Sharpless, MD, as the 15th director of the NCI. Sharpless, an oncologist with research and clinical experience, said he was humbled by the selection and is looking forward to carrying on NCI’s great mission.
Trump Cuts Obamacare Subsidies; Trump Announces Hargan as New Acting HHS Secretary; Norman Sharpless Sworn in as NCI Director
President Trump signed an executive order ending key payments to insurers selling plans in the Affordable Care Act (ACA) marketplace. The GOP has attempted to repeal and replace ACA, known as Obamacare, several times in 2017 with little success. Trump’s move is seen as the most recent attempt to dismantled Obamacare without the need for legislation. The Trump administration released a statement citing the legality of the funding as reason to withhold payments of more than $7 billion to health insurers as part of ACA’s cost-sharing reduction payments.
Governors Push Senators for 2018 ACA Funding; NCI Requests Input on Bioethics in Cancer Research; Congress Braces for Full September Agenda
Summer 2017 saw several attempts to repeal and replace the Affordable Care Act (ACA), none of which were successful. Now that the dust has started to settle—and Congress is slowly moving on to other issues—many are still dealing with the uncertainty left in the wake of the nation’s healthcare debate. This includes many concerned governors who are lobbying for funds to address their states’ current needs.
How Do You Find Clinical Trials Through the NCI’s Advanced Clinical Trials Search?
As part of the National Cancer Moonshot Initiative and in collaboration with the Presidential Innovation Fellows, the National Cancer Institute (NCI) developed and launched a new website in 2016. It provides user-friendly access to the repository of abstracts of cancer clinical trials that NCI supported.
How Are Patients Randomized to Cancer Clinical Trials?
Before any new treatment or approach is used with people in clinical trials, researchers work to understand its effects on cancer cells in the lab and in animals. Researchers design cancer clinical trials to test new ways to treat, detect, diagnose, and prevent cancer, and manage symptoms of cancer and side effects from treatment.
“Light” Cigarettes to Blame for Rise in Lung Adenocarcinoma
High-ventilation (light) cigarettes have no health benefits to smokers and have likely contributed to increased incidence of adenocarcinoma deep in the lungs, according to the results of a new study published in the Journal of the National Cancer Institute.
How NCI Is Training the Future Cancer Research Workforce
To ensure that future cancer research is of the highest quality, the National Cancer Institute (NCI) is committed to developing the best scientific minds. NCI training and funding opportunities cover a broad spectrum of disciplines for individuals at various stages in their careers, ranging from high school and graduate students to scientists, clinicians, and healthcare professionals.
UNC’s Norman Sharpless Named NCI Director; Senators Back to Work on Healthcare Bill; National Institutes of Health Director to Remain
On June 12, 2017, President Trump named Norman Sharpless, MD, as director of National Cancer Institute (NCI). Sharpless, formerly the director of the Lineberger Comprehensive Cancer Center at the University of North Carolina, is a practicing oncologist and cancer researcher. He will take over as for Doug Lowry, MD, who has been the NCI’s acting director since 2015.
Annual Cancer Report Identifies Significant Increases in Survival
As part of its Annual Report to the Nation on the Status of Cancer for 1975-2014, a group of organizations and agencies identified significant increases in cancer survival in the United States, with survival rates more than doubling for eight cancers.
Executive Order to Fight Opioid Epidemic; Trump Administration Proposes Cuts to Spending in 2017 and 2018; White House Supports April as Cancer Control Month
President Trump is a preparing a new executive order that would outline recommendations for the nation’s fight against opioid addiction. According to report released in STAT, the executive order would form a commission of four top Trump aides, including Attorney General Jeffery Sessions, Health and Human Services Secretary Tom Price, Veterans Affairs Secretary David Shulkin, and Defense Secretary James Mattis. The commission would be led by New Jersey Governor Chris Christie and would be fleshed out with another five other yet-to-be-named officials from the state government level, law enforcement, and other areas potentially impacted by the national crisis.
NCI Cancer Moonshot Funds Researchers
After the dust settled from the presidential election, Congress returned to Washington to complete some remaining legislative work before the new year. Among the newly approve legislation, the 21st Century Cures Act was passed, and it aims to have major implications for expanding oncology research in the coming months and years.
New Web Tool Seeks to Advise Cancer Survivors on Managing Health
In a joint venture between the National Cancer Institute (NCI) and the American Cancer Society (ACS), a new web tool aims to provide better understanding for cancer survivors’ treatment options and what happens to them when treatment is over. The initiative, Springboard Beyond Cancer, is meant to empower survivors by providing them when education and resources about living beyond their cancer diagnosis. Springboard Beyond Cancer aims to address the following survivorship issues for patients.